Leerink Swann Starts Vical (VICL) at Outperform; DNA Vaccine Platform Provides Multiple Opportunities

Go back to Leerink Swann Starts Vical (VICL) at Outperform; DNA Vaccine Platform Provides Multiple Opportunities
Vical, Inc. (NASDAQ: VICL) Delayed: 0.68 --0 (-0%)
Previous Close $0.68    52 Week High $4.75 
Open $6.01    52 Week Low $0.28 
Day High $0.68    P/E N/A 
Day Low $0.68    EPS $-0.36 
Volume